ePRO Resources
-
Why eSource: The Advantages of Abandoning Paper Records
2/16/2023
Eliminate transcription errors and fully leverage supporting eClinical technology to provide a reliable consistent exchange of information.
-
Driving Customer Profitability With Enterprise Platform, Pricing
2/29/2024
Explore how the solutions and approaches offered by CDS can help different research stakeholders conduct more cost-efficient clinical trials in the industry's pharmaceutical, biotech, and device sectors.
-
Creating Success With Digital Measures
8/2/2024
Recent research from the Tufts Center for the Study of Drug Development (CSDD) illuminated the substantial ROI of digital endpoints in clinical trials. Discover how to transform your trials today.
-
What Universalized Terminology Means For Decentralized Research
10/26/2022
Many DCT stakeholders have attempted to release terminology guides as it relates to their own dealings, however, there had never been a wide range of universalized DCT terms until now.
-
Choosing The Right eClinRO Solution For Reliable Trial Data
2/21/2025
Electronic clinician-reported outcomes (eClinROs) enhance the quality and consistency of clinical trial data. Discover key factors to consider when selecting an eClinRO provider.
-
The Future Of Clinical Trials Rests On A Unified CTMS Platform
8/1/2022
Discover why a unified CTMS platform is the answer for managing both the clinical trial itself and the data it produces when it comes to poorly integrated clinical trial management systems (CTMS).
-
Expanding Flexibility Of eCOA Data Collection With Controlled Interview Mode
1/31/2022
Discover how the interview mode constitutes an additional data entry mode for ePROs when clinical trial participants cannot go to the study site for a scheduled visit.
-
ePROs: How They're Transforming Oncology Research
10/30/2023
ePRO and eCOA are helping to overcome oncology-specific challenges in clinical research. Find out how you can make life easier for patients when it matters most.
-
Measuring Treatment Tolerability In Oncology: Expert Panel Discussion
2/19/2026
Learn how to synthesize individual symptomatic data into a comprehensive narrative of tolerability, ultimately enhancing the clinical value and regulatory positioning of your oncology assets.
-
Evidence Generation Evolved
6/13/2024
Explore how innovative strategies are cutting clinical trial times in half and accelerating the delivery of life-saving treatments.